To assess the activation of the Rho/ROCK signaling pathway, we measured the expression of RhoA and Smo protein, as well as the phosphorylation level of MYPT-1 in RA-FLS treated with purmorphamine or cyclopamine. The gene discussed is RHOA; the disease is rheumatoid arthritis.